stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Revenue
ICON PLC's revenue for fiscal 2025 was $8.3B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $8.2B. Over the past ten years it has ranged from $1.6B (fiscal 2015) to $8.3B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. ICON PLC ranks 6th of 47 Diagnostics & Research companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $8.3B | 0.76% |
| FY2024 | $8.2B | 0.85% |
| FY2023 | $8.1B | 4.89% |
| FY2022 | $7.7B | 41.24% |
| FY2021 | $5.5B | 95.93% |
| FY2020 | $2.8B | (0.30%) |
| FY2019 | $2.8B | 8.09% |
| FY2018 | $2.6B | 47.62% |
| FY2017 | $1.8B | 5.52% |
| FY2016 | $1.7B | 5.81% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $2.0B | (1.88%) |
| Jun 2026 | $2.1B | 1.45% |
| Mar 2026 | $2.0B | (3.72%) |
| Dec 2025 | $2.1B | 1.35% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| LH Labcorp Holdings Inc. compare | $14.6B |
| DGX Quest Diagnostics Incorporated compare | $11.8B |
| ICLR ICON PLC | $8.2B |
| ILMN Illumina, Inc. compare | $4.5B |
| CRL Charles River Laboratories International, Inc. compare | $4.0B |
| RVTY Revvity Inc. compare | $2.9B |
| MEDP Medpace Holdings, Inc. compare | $2.8B |
| QGEN QIAGEN N.V. compare | $2.1B |
| GH Guardant Health, Inc. compare | $1.3B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ICLR
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement